Industry veteran to pass the reins to accomplished leader with proven track record for scaling digital B2C and B2B companies as part of company's CEO succession plan Cars.com Inc. (NYSE: CARS) (d/b/a “Cars Commerce Inc.”), today announced that Tobias (“Tobi”) Hartmann will become the company's next Chief Executive Officer (CEO) and be appointed to the […]

(NASDAQ:NNE), Management to hold webcast today at 5:00 pm Eastern New York, N.Y., Dec. 18, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor and technology company focused on developing clean energy solutions, today reported its fiscal year 2025 financial results and

(NASDAQ:HTFL), MOUNTAIN VIEW, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) — Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), announced the American College of Cardiology (ACC) and the American Heart Association (AHA) published new scientific statements supporting the prognostic value of quantifying coronary plaque and reinforcing the critical role

(NASDAQ:SHFS), DENVER, Dec. 18, 2025 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a Safe Harbor Financial (NASDAQ: SHFS) (“Safe Harbor” or the “Company”), a provider of banking, lending, and financial services to the legal cannabis industry, announced that the federal rescheduling of cannabis represents a meaningful policy shift with long-term implications for the Company's platform. The

(NASDAQ:APLD), DALLAS, Dec. 18, 2025 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocations services for artificial intelligence, cloud, networking and blockchain workloads, will host a conference call on Wednesday, January 7, 2026, at 5:00 p.m. Eastern Time

(NASDAQ:MDLN), NORTHFIELD, Ill., Dec. 18, 2025 (GLOBE NEWSWIRE) — Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its upsized initial public offering of 248,439,654 shares of its Class A common stock at a public offering price of $29.00 per share, including the full exercise by the underwriters of their option to purchase

(NYSE:RMD),(AUST:RMD.AX), SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, beginning at approximately 10:30 a.m. (Pacific Standard Time) in San

(NasdaqGM:RNAC), FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the appointment of Adrian Bot, M.D., Ph.D., to the Company's Board of Directors. Dr. Bot is a biopharma executive with three decades of experience in research and

(NASDAQ:AVO), Founder & CEO Steve Barnard to Transition to Executive Chairman of the Board; President and COO John Pawlowski to Become CEO at the close of the Annual Meeting of Shareholders in April 2026 Board Refreshment Initiative Underway -Three New Independent Directors Appointed in Advance of Expected Retirement of Current Board Chair at close of

(NASDAQ:MDGL), CONSHOHOCKEN, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on December 15, 2025 to 4 new non-executive employees as equity inducement awards under the terms of Madrigal's 2025 Inducement Plan. The